Bioavailability and Pharmacokinetics Clinical Trial
Official title:
A Phase 1, Randomised, Open Label, 2-period Crossover, Single Centre, 3-arm, Single Dose Study to Investigate the Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsule Formation in Healthy Volunteers
HTL0018318 is a selective muscarinc M1 agonist. This study is a phase I, open label, randomised, crossover, single dose, trial in healthy volunteers to compare the relative bioavailability of HTL0018318 when given by oral aqueous solution and in capsule formulation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01991509 -
Safety and Bioavailability of IV and SC LBR-101
|
Phase 1 |